Evaluation of Safety of Pomalidomide in Combination With Dexamethasone (Low Dose) in Patients With Refractory or Relapsed and Refractory Multiple Myeloma
Clinical trial NCT01712789 · COMPLETED
Trial details
- NCT number
- NCT01712789
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-06
- Primary completion
- 2019-12-11
- Enrollment
- 682
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.